Reply to: Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer

Por Goldhirsch, A., Coates, A. S.
Publicado no Ann Oncol (2014)

Adjuvant treatment for breast cancer: the overview.

Por Gelber, R. D., Coates, A. S., Goldhirsch, A.
Publicado em 1992

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

Por Goldhirsch, A., Ingle, J. N., Gelber, R. D., Coates, A. S., Thürlimann, B., Senn, H.-J.
Publicado em 2009

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Por Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., Senn, H.-J.
Publicado em 2011

Tumour dormancy and clinical implications in breast cancer

Por Gelao, L, Criscitiello, C, Fumagalli, L, Locatelli, M, Manunta, S, Esposito, A, Minchella, I, Goldhirsch, A, Curigliano, G
Publicado em 2013

Correlation between administered treatment and patient’s living will

Por Andreoni, B, Goldhirsch, A, Orecchia, R, Venturino, M, Spirito, R, Tadini, L, Corbellini, C, Bertani, E, Veronesi, U
Publicado em 2009

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Por Coates, A. S., Winer, E. P., Goldhirsch, A., Gelber, R. D., Gnant, M., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J.
Publicado no Ann Oncol (2015)

QTc prolongation assessment in anticancer drug development: clinical and methodological issues

Por Curigliano, G, Spitaleri, G, de Braud, F, Cardinale, D, Cipolla, C, Civelli, M, Colombo, N, Colombo, A, Locatelli, M, Goldhirsch, A
Publicado em 2009

Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials

Por Huober, J., Gelber, S., Goldhirsch, A., Coates, A. S., Viale, G., Öhlschlegel, C., Price, K. N., Gelber, R. D., Regan, M. M., Thürlimann, B.
Publicado em 2012

Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity

Por Torrisi, R, Bagnardi, V, Cardillo, A, Bertolini, F, Scarano, E, Orlando, L, Mancuso, P, Luini, A, Calleri, A, Viale, G, Goldhirsch, A, Colleoni, M
Publicado em 2008

A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma

Por Rocca, A, Minucci, S, Tosti, G, Croci, D, Contegno, F, Ballarini, M, Nolè, F, Munzone, E, Salmaggi, A, Goldhirsch, A, Pelicci, P G, Testori, A
Publicado em 2009

Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer

Por Torrisi, R, Bagnardi, V, Pruneri, G, Ghisini, R, Bottiglieri, L, Magni, E, Veronesi, P, D'Alessandro, C, Luini, A, Dellapasqua, S, Viale, G, Goldhirsch, A, Colleoni, M
Publicado em 2007

Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer

Por Montagna, E, Bagnardi, V, Rotmensz, N, Rodriguez, J, Veronesi, P, Luini, A, Intra, M, Scarano, E, Cardillo, A, Torrisi, R, Viale, G, Goldhirsch, A, Colleoni, M
Publicado em 2008

The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after pro...

Por Colleoni, M., Sun, Z., Martinelli, G., Basser, R. L., Coates, A. S., Gelber, R. D., Green, M. D., Peccatori, F., Cinieri, S., Aebi, S., Viale, G., Price, K. N., Goldhirsch, A.
Publicado em 2009

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer

Por Ribi, K, Aldridge, J, Phillips, K-A, Thompson, A, Harvey, V, Thürlimann, B, Cardoso, F, Pagani, O, Coates, A S, Goldhirsch, A, Price, K N, Gelber, R D, Bernhard, J
Publicado em 2012

Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).

Por Bernhard, J., Hürny, C., Coates, A. S., Peterson, H. F., Castiglione-Gertsch, M., Gelber, R. D., Galligioni, E., Marini, G., Thürlimann, B., Forbes, J. F., Goldhirsch, A., Senn, H. J., Rudenstam, C. M.
Publicado em 1998

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report

Por Karlsson, P., Cole, B. F., Chua, B. H., Price, K. N., Lindtner, J., Collins, J. P., Kovács, A., Thürlimann, B., Crivellari, D., Castiglione-Gertsch, M., Forbes, J. F., Gelber, R. D., Goldhirsch, A., Gruber, G.
Publicado em 2012

Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial

Por Munzone, E., Giobbie-Hurder, A., Gusterson, B. A., Mallon, E., Viale, G., Thürlimann, B., Ejlertsen, B., MacGrogan, G., Bibeau, F., Lelkaitis, G., Price, K. N., Gelber, R. D., Coates, A. S., Goldhirsch, A., Colleoni, M.
Publicado no Ann Oncol (2015)

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX

Por Aebi, S., Sun, Z., Braun, D., Price, K. N., Castiglione-Gertsch, M., Rabaglio, M., Gelber, R. D., Crivellari, D., Lindtner, J., Snyder, R., Karlsson, P., Simoncini, E., Gusterson, B. A., Viale, G., Regan, M. M., Coates, A. S., Goldhirsch, A.
Publicado em 2011

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer

Por Bernhard, J, Zahrieh, D, Zhang, J J, Martinelli, G, Basser, R, Hürny, C, Forbes, J F, Aebi, S, Yeo, W, Thürlimann, B, Green, M D, Colleoni, M, Gelber, R D, Castiglione-Gertsch, M, Price, K N, Goldhirsch, A, Coates, A S
Publicado em 2008